Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00368108
Status:
COMPLETED
Last Update Posted:
2013-05-20
First Post:
2006-08-22
Brief Title:
Efficacy Safety and Tolerability of E2007 in Levodopa Treated Parkinsons Disease Patients With Motor Fluctuations
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
A Multi-Center Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy Safety and Tolerability of E2007 in Levodopa Treated Parkinsons Disease Patients With Motor Fluctuations
Status:
COMPLETED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-center randomized double-blind placebo-controlled parallel-group study of E2007 in levodopa treated Parkinsons disease patients with motor fluctuations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None